Nmda Profile, Csf

NMDA Profile, CSF

What it is

The NMDA Profile, CSF test detects antibodies against N-methyl-D-aspartate (NMDA) receptors in the cerebrospinal fluid (CSF). These antibodies are associated with autoimmune encephalitis, a neurological condition where the immune system mistakenly attacks NMDA receptors in the brain. The test helps confirm the diagnosis in patients with unexplained neurological and psychiatric symptoms.

Uses

This test is used to diagnose NMDA receptor encephalitis and related autoimmune neurological disorders. It helps differentiate autoimmune encephalitis from viral, bacterial, or psychiatric causes of symptoms. It is also useful in monitoring disease progression and response to immunotherapy in affected patients.

Symptoms That May Lead to the Test

Doctors may recommend the NMDA Profile, CSF test if you show symptoms such as sudden changes in behavior, psychosis, memory loss, seizures, abnormal movements, speech difficulties, or decreased level of consciousness. It is often ordered when standard neurological evaluations do not explain the symptoms, particularly in young adults and children.

Abnormal Results

Positive NMDA Receptor Antibodies in CSF: Strongly supports the diagnosis of NMDA receptor encephalitis. Early detection is important, as treatment with immunotherapy can significantly improve outcomes.

Negative Results: Suggest no NMDA receptor antibodies detected. However, if clinical suspicion remains high, serum testing or repeat CSF analysis may be considered to rule out the disease.

Risks

This test requires a lumbar puncture (spinal tap) to collect cerebrospinal fluid. Risks include temporary headache, back discomfort, dizziness, or, rarely, infection or bleeding at the puncture site. When performed by trained professionals, complications are uncommon.